Linden Thomas Advisory Services’s Amedisys AMED Stock Holding History

Linden Thomas Advisory Services’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,522	Closed	-$505K	–	387
2023 Q2	$505K	Buy	5,522 +104	+2%	+$8.53K	0.11%	302
2023 Q1	$399K	Buy	5,418 +334	+7%	+$28.9K	0.1%	308
2022 Q4	$425K	Buy	+5,084	New	+$458K	0.12%	271

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Linden Thomas Advisory Services's AMED Position: Q3 2023 in Review

Linden Thomas Advisory Services sold out of Amedisys (AMED) in Q3 2023, closing a stake of 5,522 shares — an estimated $505K sold.

Linden Thomas Advisory Services first reported a position in AMED in Q4 2022 and held it in 3 quarters. The position peaked at $505K in Q2 2023. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

Linden Thomas Advisory Services reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
Linden Thomas Advisory Services sold 5,522 Amedisys shares in Q3 2023, an estimated $505K.
Linden Thomas Advisory Services first reported a position in Amedisys in Q4 2022 and held it in 3 quarters.
Linden Thomas Advisory Services's Amedisys position peaked at $505K in Q2 2023.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Linden Thomas Advisory Services's 13F filing for Q3 2023, filed 20 Oct 2023.